Multiple sclerosis
Chapter 6:Diseases of the nervous system
ICD-10 G35 is a billable code used to indicate a diagnosis of multiple sclerosis.
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), leading to demyelination of nerve fibers. The condition is characterized by the formation of plaques in the brain and spinal cord, which disrupts the normal flow of electrical impulses along the nerves. Symptoms can vary widely among individuals and may include fatigue, difficulty walking, numbness or tingling, muscle weakness, and cognitive changes. The exact cause of MS remains unknown, but it is believed to involve a combination of genetic predisposition and environmental factors. MS is classified into several types, including relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). Diagnosis typically involves a combination of clinical evaluation, magnetic resonance imaging (MRI), and lumbar puncture to analyze cerebrospinal fluid. Treatment options include immunomodulatory therapies such as interferons, glatiramer acetate, and newer oral medications that aim to reduce the frequency of relapses and slow disease progression. Management of MS is multidisciplinary, often involving neurologists, rehabilitation specialists, and mental health professionals.
Comprehensive neurological examination findings, MRI results, and treatment plans.
Initial diagnosis of MS, management of relapses, and monitoring of disease progression.
Ensure accurate documentation of the type of MS and any comorbid neurological conditions.
Functional assessments, rehabilitation goals, and progress notes.
Rehabilitation following exacerbations, management of mobility issues, and coordination of care.
Document specific functional limitations and rehabilitation interventions.
Follow-up visit for MS management.
Document history, examination, and medical decision-making.
Neurology specialists should ensure detailed notes on MS symptoms and treatment.
Relapsing-remitting MS is characterized by episodes of neurological symptoms followed by periods of recovery, while primary progressive MS involves a gradual worsening of symptoms without distinct relapses.
